Zug, Switzerland

Anne Lesage

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Pharvaris Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne Lesage. Retrieved from https://idiyas.com/inventor/anne-lesage-8c3gvw8o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anne Lesage and Her Patent on Angioedema Treatment.

Introduction

Anne Lesage is an inventor associated with Pharvaris GmbH and based in Zug, Switzerland. Her patent work includes an invention concerning the prophylaxis and treatment of angioedema.

Latest Patents

The supplied information identifies one patent associated with Lesage: “Prophylaxis and Treatment of Angioedema.” The invention concerns a bradykinin B2-receptor antagonist for preventing or treating angioedema. It describes orally administering a therapeutically effective dose at least once, either as prophylactic treatment or after an acute attack, to prevent, alleviate, or treat symptoms. The record lists 1 patent.

Career Highlights

Lesage’s listed patent reflects work on an oral treatment approach for angioedema. The supplied information associates her with Pharvaris GmbH.

Collaborations

Peng Lu is identified in the supplied information as a coworker. The patent description focuses on the therapeutic use of the bradykinin B2-receptor antagonist.

Conclusion

Anne Lesage’s listed patent addresses oral prophylaxis and treatment for angioedema, highlighting her connection to pharmaceutical innovation at Pharvaris GmbH.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…